Copper-Catalyzed Direct Transformation of Secondary Allylic and Benzylic Alcohols into Azides and Amides: An Efficient Utility of Azide as a Nitrogen Source
作者:Balaji V. Rokade、Karthik Gadde、Kandikere Ramaiah Prabhu
DOI:10.1002/ejoc.201500010
日期:2015.4
synthesis of amides has been explored by using secondary alcohols, Cu(ClO4)2·6H2O as a catalyst, and trimethylsilyl azide (TMSN3) as a nitrogen source in the presence of 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) at ambient temperature. This method has been successfully adapted to the preparation of azides directly from their corresponding alcohols and offers excellent chemoselectivity in the formation
Niestroj, Michael; Neumann, Wilhelm P.; Thies, Olaf, Chemische Berichte, 1994, vol. 127, # 6, p. 1131 - 1136
作者:Niestroj, Michael、Neumann, Wilhelm P.、Thies, Olaf
DOI:——
日期:——
Synthesis, structure, and biological assay of cinnamic amides as potential EGFR kinase inhibitors
作者:Mao Zhang、Xiang Lu、Hong-Jia Zhang、Na Li、Yu Xiao、Hai-Liang Zhu、Yong-Hao Ye
DOI:10.1007/s00044-012-0093-z
日期:2013.2
A series of derivatives of cinnamic amide (compounds 2a-2v) were synthesized and evaluated for antiproliferative activities against the human breast cancer cell line MCF-7- and EGFR-inhibitory activities. The structures of compounds 2b and 2i were determined by single-crystal X-ray diffraction analysis. Compounds 2f and 2j showed moderate EGFR inhibitory activity with IC50 values of 5.16 and 7.37 mu M, respectively. Docking simulation of compound 2f was carried out to illustrate the binding mode of the molecule into the EGFR active site. Structure-activity relationship analysis found that the N-phenyl rings are required for enhancing the activities.
Monoamine oxidase inhibition by selected anilide derivatives
作者:Lesetja Legoabe、Johann Kruger、Anél Petzer、Jacobus J. Bergh、Jacobus P. Petzer
DOI:10.1016/j.ejmech.2011.08.036
日期:2011.10
A series of anilide derivatives were synthesized and evaluated as inhibitors of recombinant human monoamine oxidase (MAO) A and B. The most potent inhibitors among the derivatives that were initially evaluated were (2E)-N-(3-chlorophenyl)-3-phenylprop-2-enamide (2c) and (2E)-N-(3-bromophenyl)-3-phenylprop-2-enamide (2d) with IC50 values of 0.53 mu M and 0.45 mu M, respectively. These derivatives exhibited reversible and selective inhibition of MAO-B with binding affinities 37 fold higher for MAO-B than for MAO-A. Analysis of the possible binding interactions of these inhibitors with active site models of human MAO-A and B led to the design of phenolic and benzonitrile derivatives of 2c and 2d. Among these were (2E)-N-(3-chlorophenyl)-3-(4-hydroxyphenyl)prop-2-enamide (7c) and (2E)-N-(3-bromophenyl)-3-(4-hydroxyphenyl)prop-2-enamide (7d) which inhibited MAO-B selectively and reversibly with IC50 values of 0.032 mu M and 0.026 mu M, respectively. These inhibitors were at least 14 fold more potent than 2c and 2d. This study concludes that N,3-diphenylprop-2-enamide is a suitable scaffold for the design of selective MAO-B inhibitors and structural modifications to enhance the binding affinities of the inhibitors for the MAO-B active site include substitution with halogens on the N-phenyl ring and substitution with hydroxyl and nitrile functional groups on the para and meta positions, respectively, of the C3 phenyl ring. Possible binding modes of these structures within the MAO-B active site are proposed with the emphasis on the interactions of the inhibitor halogens and the hydroxyl and nitrile functional groups with active site residues and water molecules. (C) 2011 Elsevier Masson SAS. All rights reserved.
The C/At is out of the bag: a gene for mental illness